PubRank

José Alvarez-Sabín

Author PubWeight™ 82.20‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial). Lancet 2012 2.69
2 Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke. Circulation 2003 2.30
3 Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke. Stroke 2006 2.27
4 Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator. Stroke 2005 2.24
5 Poststroke C-reactive protein is a powerful prognostic tool among candidates for thrombolysis. Stroke 2006 2.22
6 Tandem internal carotid artery/middle cerebral artery occlusion: an independent predictor of poor outcome after systemic thrombolysis. Stroke 2006 2.20
7 Patterns and predictors of early risk of recurrence after transient ischemic attack with respect to etiologic subtypes. Stroke 2007 2.03
8 Higher risk of further vascular events among transient ischemic attack patients with diffusion-weighted imaging acute ischemic lesions. Stroke 2004 1.91
9 Diffusion-weighted MR imaging in the acute phase of transient ischemic attacks. AJNR Am J Neuroradiol 2002 1.83
10 Thrombolysis-related hemorrhagic infarction: a marker of early reperfusion, reduced infarct size, and improved outcome in patients with proximal middle cerebral artery occlusion. Stroke 2002 1.83
11 Prediction of early neurological deterioration using diffusion- and perfusion-weighted imaging in hyperacute middle cerebral artery ischemic stroke. Stroke 2002 1.80
12 C-reactive protein predicts further ischemic events in first-ever transient ischemic attack or stroke patients with intracranial large-artery occlusive disease. Stroke 2003 1.78
13 Trevo System: single-center experience with a novel mechanical thrombectomy device. J Neuroimaging 2011 1.73
14 Comparison of triflusal and aspirin for prevention of vascular events in patients after cerebral infarction: the TACIP Study: a randomized, double-blind, multicenter trial. Stroke 2003 1.67
15 Improving the predictive accuracy of recanalization on stroke outcome in patients treated with tissue plasminogen activator. Stroke 2003 1.61
16 Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers. Stroke 2008 1.54
17 Fas system activation in perihematomal areas after spontaneous intracerebral hemorrhage. Stroke 2008 1.52
18 [Intravenous tissue-type plasminogen activator for the treatment of acute cerebral ischemia]. Med Clin (Barc) 2003 1.41
19 Matrix metalloproteinase-9 concentration after spontaneous intracerebral hemorrhage. J Neurosurg 2003 1.27
20 Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials. Stroke 2002 1.24
21 Temporal profile of recanalization after intravenous tissue plasminogen activator: selecting patients for rescue reperfusion techniques. Stroke 2006 1.17
22 Safety and efficacy of intravenous tissue plasminogen activator stroke treatment in the 3- to 6-hour window using multimodal transcranial Doppler/MRI selection protocol. Stroke 2005 1.16
23 Acute hyperglycemia state is associated with lower tPA-induced recanalization rates in stroke patients. Stroke 2005 1.12
24 Vascular MMP-9/TIMP-2 and neuronal MMP-10 up-regulation in human brain after stroke: a combined laser microdissection and protein array study. J Proteome Res 2009 1.11
25 A large screening of angiogenesis biomarkers and their association with neurological outcome after ischemic stroke. Atherosclerosis 2011 1.09
26 Differential pattern of tissue plasminogen activator-induced proximal middle cerebral artery recanalization among stroke subtypes. Stroke 2004 1.09
27 A matrix metalloproteinase protein array reveals a strong relation between MMP-9 and MMP-13 with diffusion-weighted image lesion increase in human stroke. Stroke 2005 1.08
28 Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke. Stroke 2005 1.08
29 Mobilization, endothelial differentiation and functional capacity of endothelial progenitor cells after ischemic stroke. Microvasc Res 2010 1.07
30 Plasmatic level of neuroinflammatory markers predict the extent of diffusion-weighted image lesions in hyperacute stroke. J Cereb Blood Flow Metab 2003 1.06
31 [Lipid profile in the hyperacute phase of ischemic stroke allows to decide cholesterol-lowering therapy]. Med Clin (Barc) 2005 1.05
32 Speed of tPA-induced clot lysis predicts DWI lesion evolution in acute stroke. Stroke 2007 1.05
33 Diagnosis and quantification of patent foramen ovale. Which is the reference technique? Simultaneous study with transcranial Doppler, transthoracic and transesophageal echocardiography. Rev Esp Cardiol 2011 1.04
34 Admission fibrinolytic profile is associated with symptomatic hemorrhagic transformation in stroke patients treated with tissue plasminogen activator. Stroke 2004 1.00
35 Recanalization and reperfusion therapies for acute ischemic stroke. Cerebrovasc Dis 2009 0.96
36 Progression of symptomatic intracranial large artery atherosclerosis is associated with a proinflammatory state and impaired fibrinolysis. Stroke 2008 0.96
37 Citicoline in intracerebral haemorrhage: a double-blind, randomized, placebo-controlled, multi-centre pilot study. Cerebrovasc Dis 2006 0.95
38 Role of fibrinogen levels and factor XIII V34L polymorphism in thrombolytic therapy in stroke patients. Stroke 2006 0.95
39 Outcomes of a contemporary cohort of 536 consecutive patients with acute ischemic stroke treated with endovascular therapy. Stroke 2014 0.93
40 Thrombin-activable fibrinolysis inhibitor levels in the acute phase of ischemic stroke. Stroke 2003 0.90
41 Basic mechanisms in intracranial large-artery atherosclerosis: advances and challenges. Cerebrovasc Dis 2005 0.90
42 Reversible hemichorea associated with extracranial carotid artery stenosis. J Neurol Sci 2011 0.90
43 Plasma VAP-1/SSAO activity predicts intracranial hemorrhages and adverse neurological outcome after tissue plasminogen activator treatment in stroke. Stroke 2010 0.89
44 Silent myocardial ischemia in patients with symptomatic intracranial atherosclerosis: associated factors. Stroke 2005 0.89
45 Stroke after prolonged air travel associated with a pulmonary arteriovenous malformation. J Neurol Sci 2010 0.89
46 Do bubble characteristics affect recanalization in stroke patients treated with microbubble-enhanced sonothrombolysis? Ultrasound Med Biol 2008 0.88
47 Safety profile of tissue plasminogen activator treatment among stroke patients carrying a common polymorphism (C-1562T) in the promoter region of the matrix metalloproteinase-9 gene. Stroke 2003 0.88
48 Lipoprotein-associated phospholipase A(2) activity is associated with large-artery atherosclerotic etiology and recurrent stroke in TIA patients. Cerebrovasc Dis 2011 0.87
49 Trevo versus solitaire a head-to-head comparison between two heavy weights of clot retrieval. J Neuroimaging 2012 0.86
50 Stentrievers versus other endovascular treatment methods for acute stroke: comparison of procedural results and their relationship to outcomes. J Neurointerv Surg 2013 0.84
51 Outcomes of intravenous thrombolysis after dissemination of the stroke code and designation of new referral hospitals in Catalonia: the Catalan Stroke Code and Thrombolysis (Cat-SCT) Monitored Study. Stroke 2011 0.84
52 Headache in cerebral hemorrhage is associated with inflammatory markers and higher residual cavity. Headache 2005 0.83
53 Angiogenesis in symptomatic intracranial atherosclerosis: predominance of the inhibitor endostatin is related to a greater extent and risk of recurrence. Stroke 2004 0.83
54 Admission fibrinolytic profile predicts clot lysis resistance in stroke patients treated with tissue plasminogen activator. Thromb Haemost 2004 0.83
55 Reperfusion therapy for acute stroke improves outcome by decreasing neuroinflammation. Transl Stroke Res 2010 0.83
56 Mutational analysis of the Cu/Zn superoxide dismutase gene in a Catalan ALS population: should all sporadic ALS cases also be screened for SOD1? J Neurol Sci 2006 0.81
57 Role of the MMP9 gene in hemorrhagic transformations after tissue-type plasminogen activator treatment in stroke patients. Stroke 2012 0.81
58 Lipoprotein-associated phospholipase A2 testing usefulness among patients with symptomatic intracranial atherosclerotic disease. Atherosclerosis 2011 0.81
59 MRI findings in aphasic status epilepticus. Epilepsia 2008 0.81
60 Timing of recanalization after microbubble-enhanced intravenous thrombolysis in basilar artery occlusion. Stroke 2007 0.80
61 Absence of usefulness of ABCD score in the early risk of stroke of transient ischemic attack patients. Stroke 2007 0.80
62 Ischemic stroke outcome and early infection: its deleterious effect seems to operate also among tissue plasminogen activator-treated patients. Eur Neurol 2011 0.79
63 Investigating silent strokes in hypertensives: a magnetic resonance imaging study (ISSYS): rationale and protocol design. BMC Neurol 2013 0.79
64 CD40-1C>T polymorphism (rs1883832) is associated with brain vessel reocclusion after fibrinolysis in ischemic stroke. Pharmacogenomics 2010 0.78
65 Immunological biomarkers improve the accuracy of clinical risk models of infection in the acute phase of ischemic stroke. Cerebrovasc Dis 2013 0.78
66 Role of endogenous granulocyte-macrophage colony stimulating factor following stroke and relationship to neurological outcome. Curr Neurovasc Res 2009 0.78
67 [Usefulness of urgent combined carotid/transcranial ultrasound testing in early prognosis of TIA patients]. Med Clin (Barc) 2006 0.77
68 Endogenous activated protein C predicts hemorrhagic transformation and mortality after tissue plasminogen activator treatment in stroke patients. Cerebrovasc Dis 2009 0.77
69 ACE gene polymorphisms influence t-PA-induced brain vessel reopening following ischemic stroke. Neurosci Lett 2006 0.77
70 Prognostic value of plasma chitotriosidase activity in acute stroke patients. Int J Stroke 2013 0.76
71 Cryptogenic stroke, aortic arch atheroma and patent foramen ovale. Cerebrovasc Dis 2007 0.75
72 [Delayed onset progressive cerebral arteriopathy after radiation]. Med Clin (Barc) 2004 0.75
73 [Malformations of cortical development in adult patients with epilepsy: a series of 79 cases]. Rev Neurol 2014 0.75
74 Fluorescent molecular peroxidation products: a prognostic biomarker of early neurologic deterioration after thrombolysis. Stroke 2013 0.75